Latest Stocks: Radius Health (RDUS) Receives Daily News Impact Score of 0.51

Latest Stocks: Radius Health (RDUS) Receives Daily News Impact Score of 0.51

News coverage about Radius Health (NASDAQ:RDUS) has trended very positive recently, according to Alpha One Sentiment. The research group, a unit of Accern, ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Alpha One ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Radius Health earned a daily sentiment score of 0.51 on Alpha One’s scale. Alpha One also gave media headlines about the biopharmaceutical company an impact score of 0 out of 100, meaning that recent press coverage is extremely unlikely to have an impact on the company’s share price in the next few days.

Here are some of the news articles that may have effected Alpha One Sentiment Analysis’s analysis:

A number of research analysts recently issued reports on the company. JPMorgan Chase & Co. restated a “buy” rating on shares of Radius Health in a research report on Saturday, March 11th. Jefferies Group LLC set a $34.00 price objective on Radius Health and gave the company a “hold” rating in a research report on Monday. Canaccord Genuity set a $85.00 price objective on Radius Health and gave the company a “buy” rating in a research report on Saturday, March 11th. Maxim Group set a $24.00 price target on Radius Health and gave the stock a “sell” rating in a research report on Saturday, March 11th. Finally, Cantor Fitzgerald set a $65.00 price target on Radius Health and gave the stock a “buy” rating in a research report on Sunday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $56.83. Shares of Radius Health (NASDAQ:RDUS) opened at 38.75 on Tuesday. The firm’s market cap is $1.68 billion. The stock has a 50 day moving average price of $36.38 and a 200 day moving average price of $41.06. Radius Health has a one year low of $31.58 and a one year high of $59.88.

Radius Health (NASDAQ:RDUS) last announced its quarterly earnings results on Thursday, May 4th. The biopharmaceutical company reported ($1.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.18) by $0.14. During the same period in the prior year, the business posted ($0.94) EPS. On average, equities research analysts forecast that Radius Health will post ($4.42) EPS for the current year. In other Radius Health news, major shareholder Growth N. V. Biotech acquired 30,000 shares of Radius Health stock in a transaction that occurred on Friday, March 17th. The shares were bought at an average price of $38.41 per share, with a total value of $1,152,300.00. Following the completion of the purchase, the insider now directly owns 4,490,399 shares in the company, valued at approximately $172,476,225.59. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Growth N. V. Biotech acquired 38,279 shares of Radius Health stock in a transaction that occurred on Friday, March 10th. The stock was acquired at an average cost of $39.17 per share, for a total transaction of $1,499,388.43. Following the purchase, the insider now owns 4,398,678 shares of the company’s stock, valued at $172,296,217.26. The disclosure for this purchase can be found here. Insiders have bought 678,400 shares of company stock valued at $24,321,465 over the last quarter. Company insiders own 16.80% of the company’s stock.

Radius Health (NASDAQ:RDUS) last announced its quarterly earnings results on Thursday, May 4th. The biopharmaceutical company reported ($1.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.18) by $0.14. During the same period in the prior year, the business posted ($0.94) EPS. On average, equities research analysts forecast that Radius Health will post ($4.42) EPS for the current year. Radius Health Company Profile

Related posts

Leave a Comment